Elizabeth Coulthard

Experts / Elizabeth Coulthard

Elizabeth Coulthard

Associate Professor in Dementia Neurology, University of Bristol

New Alzheimer’s drug slows cognitive decline – and may be available as early as next year

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease

New Alzheimer’s drug slows cognitive decline – and may be available as early as next year

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease

By Bernadette McGuinness, Elizabeth Coulthard

Clinical Articles

Neurology

Elizabeth Coulthard

Associate Professor in Dementia Neurology, University of Bristol

More from this expert

New Alzheimer’s drug slows cognitive decline – and may be available as early as next year

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease

New Alzheimer’s drug slows cognitive decline – and may be available as early as next year

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Last chance - $155 special ends midnight Sunday!

This is your last chance to secure discounted registration to both national seminars before prices increase on Monday! You're invited to attend Australia's most popular seminars for GPs and healthcare professionals.

Upcoming Healthed Webcast

POTS – What You Need to Know

Tuesday 17th February, 7pm - 9pm AEDT

Speaker

Prof Dennis Lau

Cardiac Electrophysiologist; The Royal Adelaide Hospital; Clinical Professor, The University of Adelaide

Hear the latest evidence-based management options for POTS - a common, yet poorly recognised and misunderstood autonomic dysfunction condition in our community. Join Prof Dennis Lau for an update on POTS, who is at risk, presenting symptoms and how it can be diagnosed in the primary care setting.

Elizabeth Coulthard

Associate Professor in Dementia Neurology, University of Bristol

More from this expert

New Alzheimer’s drug slows cognitive decline – and may be available as early as next year

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease

New Alzheimer’s drug slows cognitive decline – and may be available as early as next year

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Last chance - $155 special ends midnight Sunday!

This is your last chance to secure discounted registration to both national seminars before prices increase on Monday! You're invited to attend Australia's most popular seminars for GPs and healthcare professionals.

Upcoming Healthed Webcast

POTS – What You Need to Know

Tuesday 17th February, 7pm - 9pm AEDT

Speaker

Prof Dennis Lau

Cardiac Electrophysiologist; The Royal Adelaide Hospital; Clinical Professor, The University of Adelaide

Hear the latest evidence-based management options for POTS - a common, yet poorly recognised and misunderstood autonomic dysfunction condition in our community. Join Prof Dennis Lau for an update on POTS, who is at risk, presenting symptoms and how it can be diagnosed in the primary care setting.